Ferroptosis inducer-7
Ferroptosis inducer-7 is an orally active and selective ferroptosis inducer via inositol 1,4,5-trisphosphate receptor (IP3R)/calcium release-activated calcium channel protein (ORAI). Ferroptosis inducer-7 exhibits a notable effect in alleviating anemia symptoms, suppressing bone marrow CTLs activation, and improving hematopoietic function in immune-mediated bone marrow failure. Ferroptosis inducer-7 can be studied in research for aplastic anemia.
For research use only. We do not sell to patients.
- CAS No.: 2723569-00-2
- Formula: C29H31NO6
- Molecular Weight:489.56
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All MEK Isoforms
More
Biological Activity
Description
In Vitro
Ferroptosis inducer-7 (Compound 3a-M1) (1-10 μM, 72 h) significantly inhibits the proliferation of CD8+ T cells, as well as the release of IFN-γ and TNF-α in lymph nodes of BALB/c mice[1].
Ferroptosis inducer-7 (7.5-480 μM, 72 h) selectively inhibits the proliferation of cytotoxic lymphocyte line-2 (CTLL-2) compared to other immune cell lines[1].
Ferroptosis inducer-7 (7.5-30 μM, 16 h) suggests the inhibition of CTL function is due to the activation of Ferroptosis in CTLL-2 treated with IL-2[1].
Ferroptosis inducer-7 (10 μM, 45 min) increases the extracellular Ca2+ influx om CTLs, which is triggered by the IP3R /ORAI calcium channels[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:IL-2 stimulated CTLL-2 cell line
-
Concentration:7.5-30 μM
-
Incubation Time:16 h
-
Result:Showed a significant increase in the phosphorylation levels of mitogen-activated protein kinase, ERK and p38.
Activated the MEK/ERK and p38 MAPK signaling pathway.
-
Cell Line:IL-2 stimulated CTLL-2 cell line
-
Concentration:7.5-480 μM
-
Incubation Time:72 h
-
Result:Showed the IC50 of Ferroptosis inducer-7 for IL-2-treated CTLL-2 (37.87 μM) was much lower than that for other immune cell lines, such as THP-1 (124.7 μM), HL-60 (132.6 μM), RAW264.7 (491.8 μM), HepG2 (491.9 μM), NRK-52E (705.1 μM), and IEC-6 (84.29 μM).
In Vivo
Ferroptosis inducer-7 (5-15 mg/kg, p.o., 21 d) improves survival rate, alleviates anemia symptoms, and improves hematopoietic function of immune-mediated bone marrow failure model in C57BL/6J mice model, particularly during the early stages of bone marrow failure[1].
Ferroptosis inducer-7 (5-15 mg/kg, p.o., one single dose) suppresses the proportion of T cells, especially CD8+ cells and CD8+/ CD4+ ratio in the bone marrow of aplastic anemia C57BL/6J mice[1].
Ferroptosis inducer-7 (10 g/kg, p.o., one single dose) causes no abnormalities in mice models, indicating the maximum tolerated dose exceeds 10 g/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Immune-mediated bone marrow failure BALB/c mice model[1]
-
Dosage:10 mg/kg, 14 d
-
Administration:Oral gavage (p.o.)
-
Result:Elevated body weight, peripheral red blood cells, hemoglobin levels, and platelet cells in mice.
Improved histopathological changes in the bone marrow, including increased nucleated cells, a restored nucleated-to-red blood cell ratio and a decrease in abnormal proportion of lymphocytes.
-
Animal Model:Aplastic anemia C57BL/6J mice[1]
-
Dosage:5-15 mg/kg, one single dose
-
Administration:Oral gavage (p.o.)
-
Result:Reduced the proportion of effector CD8+ T cells, and increased memory CD8+ T cells.
Suppressed the level of IFN-γ and hyperactivation of CTLs in the bone marrow of AA mice.
Chemical Information
-
CAS No. 2723569-00-2
-
Molecular Weight 489.56
-
Formula C29H31NO6
-
SMILES
O=C(/C=C/C1=CC=CC=C1)OC2=C3[C@]45[C@@](C=C(C(C5)=O)OC)([H])[C@](N(CC4)C)([H])CC3=C(C=C2OC)CO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Calcium Spark Assay
Calcium sparks are localized, transient increases in intracellular calcium concentration ([Ca2+]i) that occur in cardiac myocytes and represent elementary events underlying excitation-contraction coupling. These events are generated by the coordinated opening of clusters of ryanodine receptors (RyRs) on the sarcoplasmic reticulum membrane, leading to a brief release of Ca2+ into the cytosol. The detection and analysis of calcium sparks provide insights into the mechanisms of calcium handling and signaling in cardiac cells. Imaging techniques using fluorescent calcium indicators such as Fluo-3 are employed to visualize these subcellular calcium transients with high spatial and temporal resolution. The protocol is based on established methodologies described in primary literature for both experimental measurement and automated analysis of calcium sparks.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)